on INNATE PHARMA (EPA:IPH)
Innate Pharma reveals its 2026 financial calendar
Innate Pharma SA, a biotechnology company, has released its financial calendar for 2026 from Marseille. This schedule includes several key publications: 2025 annual results on March 26, first-quarter revenue on May 13, half-year results on September 17, and third-quarter revenue on November 5. The Annual General Meeting is scheduled for May 21. These reports will be released before the opening of the CET markets.
Innate Pharma, listed on Euronext Paris and Nasdaq, develops immunotherapeutic treatments against cancer. Its expertise includes, among other things, the development of innovative and differentiated antibodies.
R. P.
Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all INNATE PHARMA news